Stem Cell Developer Mesoblast Seeks Bone Marrow Therapy by 2012
May 12 (Bloomberg) — Mesoblast Ltd. , an Australian developer of stem-cell therapies, aims to introduce its first product by 2012 after agreeing to buy the shares of Angioblast Systems Inc.
[Read the full article here]Related News:
Stem Cell Developer Mesoblast Seeks Bone Marrow Therapy …
Mesoblast to acquire Angioblast and speed up stem cell …
Cephalon Buys Rights to Mesoblast Stem Cell Therapies